Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis

Jeong Eun Kim, Ji Man Han, Cho Rong Park, Kum Joo Shin, Curie Ahn, Jae Young Seong, Jong-Ik Hwang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: GPR56 is an orphan G-protein-coupled receptor of the adhesion family involved in brain development. In some cancer cells and tissues, GPR56 is highly expressed and may contribute to tumorigenesis phenotypes such as cell adhesion and metastasis. Although the ligand for GPR56 is unknown, the overexpression of the receptor induces the activity of several transcription factors. We identified five splicing forms of GPR56 by searching the genome database. In this study, we tried to assess the properties of the splicing variants on the activation of the transcription factors. Methods: Genome structure of human GPR56 genes was analyzed using the Ensembl genome browser. All splicing variants were constructed using PCR with the GPR56 wild-type gene as template and the appropriate primers and their expression was verified by western blotting. We examined the effect of GPR56 splicing forms on the cellular responses through reporter gene assay with various promoters. We also confirmed the GPR56-mediated transcriptional activity by silencing GPR56 expression through shRNA-mediated RNA interference. Results: We found that the coding sequence of GPR56 consist of 13 exons and alternative splicing occurs in the second and tenth exons. In reporter gene assays, GPR56 overexpression increased the activity of the serum-response element, NFAT, and E2F response elements, whereas this overexpression downregulated c-myc and p53 response element activity. Furthermore, increased promoter activity of the COX2, iNOS, and VEGF genes was observed. Variants 1 and 2 potently enhanced SRE-mediated transcription compared with wild-type GPR56. Variants 3 and 4 hardly affect the activity of the promoters. Conclusion: These results suggested that the splicing of GPR56 may induce differential tumorigenic responses owing to their varied ability to activate transcription factors.

Original languageEnglish
Pages (from-to)47-53
Number of pages7
JournalJournal of Cancer Research and Clinical Oncology
Volume136
Issue number1
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

G-Protein-Coupled Receptors
Carcinogenesis
Transcription Factors
Response Elements
Reporter Genes
Exons
Serum Response Element
Genome
Genes
Alternative Splicing
Human Genome
RNA Interference
Cell Adhesion
Vascular Endothelial Growth Factor A
Small Interfering RNA
Down-Regulation
Western Blotting
Databases
Neoplasm Metastasis
Ligands

Keywords

  • GPR56
  • Reporter gene assay
  • RNA interference
  • Splicing variants
  • Tumorigenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis. / Kim, Jeong Eun; Han, Ji Man; Park, Cho Rong; Shin, Kum Joo; Ahn, Curie; Seong, Jae Young; Hwang, Jong-Ik.

In: Journal of Cancer Research and Clinical Oncology, Vol. 136, No. 1, 01.01.2010, p. 47-53.

Research output: Contribution to journalArticle

@article{5eb378fc7dfa4de3a25176e0ae6d1653,
title = "Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis",
abstract = "Purpose: GPR56 is an orphan G-protein-coupled receptor of the adhesion family involved in brain development. In some cancer cells and tissues, GPR56 is highly expressed and may contribute to tumorigenesis phenotypes such as cell adhesion and metastasis. Although the ligand for GPR56 is unknown, the overexpression of the receptor induces the activity of several transcription factors. We identified five splicing forms of GPR56 by searching the genome database. In this study, we tried to assess the properties of the splicing variants on the activation of the transcription factors. Methods: Genome structure of human GPR56 genes was analyzed using the Ensembl genome browser. All splicing variants were constructed using PCR with the GPR56 wild-type gene as template and the appropriate primers and their expression was verified by western blotting. We examined the effect of GPR56 splicing forms on the cellular responses through reporter gene assay with various promoters. We also confirmed the GPR56-mediated transcriptional activity by silencing GPR56 expression through shRNA-mediated RNA interference. Results: We found that the coding sequence of GPR56 consist of 13 exons and alternative splicing occurs in the second and tenth exons. In reporter gene assays, GPR56 overexpression increased the activity of the serum-response element, NFAT, and E2F response elements, whereas this overexpression downregulated c-myc and p53 response element activity. Furthermore, increased promoter activity of the COX2, iNOS, and VEGF genes was observed. Variants 1 and 2 potently enhanced SRE-mediated transcription compared with wild-type GPR56. Variants 3 and 4 hardly affect the activity of the promoters. Conclusion: These results suggested that the splicing of GPR56 may induce differential tumorigenic responses owing to their varied ability to activate transcription factors.",
keywords = "GPR56, Reporter gene assay, RNA interference, Splicing variants, Tumorigenesis",
author = "Kim, {Jeong Eun} and Han, {Ji Man} and Park, {Cho Rong} and Shin, {Kum Joo} and Curie Ahn and Seong, {Jae Young} and Jong-Ik Hwang",
year = "2010",
month = "1",
day = "1",
doi = "10.1007/s00432-009-0635-z",
language = "English",
volume = "136",
pages = "47--53",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis

AU - Kim, Jeong Eun

AU - Han, Ji Man

AU - Park, Cho Rong

AU - Shin, Kum Joo

AU - Ahn, Curie

AU - Seong, Jae Young

AU - Hwang, Jong-Ik

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Purpose: GPR56 is an orphan G-protein-coupled receptor of the adhesion family involved in brain development. In some cancer cells and tissues, GPR56 is highly expressed and may contribute to tumorigenesis phenotypes such as cell adhesion and metastasis. Although the ligand for GPR56 is unknown, the overexpression of the receptor induces the activity of several transcription factors. We identified five splicing forms of GPR56 by searching the genome database. In this study, we tried to assess the properties of the splicing variants on the activation of the transcription factors. Methods: Genome structure of human GPR56 genes was analyzed using the Ensembl genome browser. All splicing variants were constructed using PCR with the GPR56 wild-type gene as template and the appropriate primers and their expression was verified by western blotting. We examined the effect of GPR56 splicing forms on the cellular responses through reporter gene assay with various promoters. We also confirmed the GPR56-mediated transcriptional activity by silencing GPR56 expression through shRNA-mediated RNA interference. Results: We found that the coding sequence of GPR56 consist of 13 exons and alternative splicing occurs in the second and tenth exons. In reporter gene assays, GPR56 overexpression increased the activity of the serum-response element, NFAT, and E2F response elements, whereas this overexpression downregulated c-myc and p53 response element activity. Furthermore, increased promoter activity of the COX2, iNOS, and VEGF genes was observed. Variants 1 and 2 potently enhanced SRE-mediated transcription compared with wild-type GPR56. Variants 3 and 4 hardly affect the activity of the promoters. Conclusion: These results suggested that the splicing of GPR56 may induce differential tumorigenic responses owing to their varied ability to activate transcription factors.

AB - Purpose: GPR56 is an orphan G-protein-coupled receptor of the adhesion family involved in brain development. In some cancer cells and tissues, GPR56 is highly expressed and may contribute to tumorigenesis phenotypes such as cell adhesion and metastasis. Although the ligand for GPR56 is unknown, the overexpression of the receptor induces the activity of several transcription factors. We identified five splicing forms of GPR56 by searching the genome database. In this study, we tried to assess the properties of the splicing variants on the activation of the transcription factors. Methods: Genome structure of human GPR56 genes was analyzed using the Ensembl genome browser. All splicing variants were constructed using PCR with the GPR56 wild-type gene as template and the appropriate primers and their expression was verified by western blotting. We examined the effect of GPR56 splicing forms on the cellular responses through reporter gene assay with various promoters. We also confirmed the GPR56-mediated transcriptional activity by silencing GPR56 expression through shRNA-mediated RNA interference. Results: We found that the coding sequence of GPR56 consist of 13 exons and alternative splicing occurs in the second and tenth exons. In reporter gene assays, GPR56 overexpression increased the activity of the serum-response element, NFAT, and E2F response elements, whereas this overexpression downregulated c-myc and p53 response element activity. Furthermore, increased promoter activity of the COX2, iNOS, and VEGF genes was observed. Variants 1 and 2 potently enhanced SRE-mediated transcription compared with wild-type GPR56. Variants 3 and 4 hardly affect the activity of the promoters. Conclusion: These results suggested that the splicing of GPR56 may induce differential tumorigenic responses owing to their varied ability to activate transcription factors.

KW - GPR56

KW - Reporter gene assay

KW - RNA interference

KW - Splicing variants

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=71449087282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71449087282&partnerID=8YFLogxK

U2 - 10.1007/s00432-009-0635-z

DO - 10.1007/s00432-009-0635-z

M3 - Article

C2 - 19572147

AN - SCOPUS:71449087282

VL - 136

SP - 47

EP - 53

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 1

ER -